We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Verisk Analytics
VRSK
$25B
| $64.8M | 0.13% |
374,594
+370,953
| +10,188% | +$69.2M |
|
152
AbbVie
ABBV
$435B
| $64.6M | 0.13% |
421,592
-778,337
| -65% | -$119M |
|
153
MSCI
MSCI
$40.9B
| $64.5M | 0.13% |
+156,428
| New | +$68.1M |
|
154
Perrigo
PRGO
$1.78B
| $64.2M | 0.13% |
1,581,880
+1,184,013
| +298% | +$44M |
|
155
Sherwin-Williams
SHW
$89.8B
| $63.9M | 0.13% |
285,249
+68,204
| +31% | +$17.5M |
|
156
Fortune Brands Innovations
FBIN
$6.06B
| $63.6M | 0.13% |
1,242,789
+1,061,118
| +584% | +$62.2M |
|
157
Amgen
AMGN
$222B
| $62.8M | 0.13% |
258,228
-61,702
| -19% | -$15.1M |
|
158
Waste Management
WM
$91B
| $62.2M | 0.13% |
406,311
-324,915
| -44% | -$50.9M |
|
|
APLS
159
DELISTED
Apellis Pharmaceuticals
APLS
| $61.9M | 0.13% |
1,368,407
+453,244
| +50% | +$20.7M |
|
160
MasTec
MTZ
$21.9B
| $61.8M | 0.13% |
861,978
+250,783
| +41% | +$19.6M |
|
161
Aflac
AFL
$63.4B
| $61.7M | 0.13% |
1,115,422
+1,007,362
| +932% | +$59.5M |
|
162
Constellation Energy
CEG
$96.4B
| $61.4M | 0.13% |
1,072,064
+970,233
| +953% | +$58.4M |
|
163
J.M. Smucker
SJM
$12.8B
| $61.2M | 0.13% |
+478,278
| New | +$63.8M |
|
164
Micron Technology
MU
$991B
| $60.9M | 0.13% |
1,102,252
-1,815,002
| -62% | -$123M |
|
165
PUT
Alphabet (Google) Class C
GOOG
$4.32T
| $60.6M | 0.12% |
554,000
-922,000
| -62% | -$109M |
|
166
Repligen
RGEN
$9.25B
| $60.6M | 0.12% |
372,877
+8,630
| +2% | +$1.36M |
|
167
Xenon Pharmaceuticals
XENE
$6.12B
| $60.5M | 0.12% |
1,990,372
+456,314
| +30% | +$13.8M |
|
168
Zoom
ZM
$30.6B
| $60.3M | 0.12% |
558,876
+154,337
| +38% | +$16.3M |
|
169
HubSpot
HUBS
$10.5B
| $60.2M | 0.12% |
200,239
+147,902
| +283% | +$54M |
|
170
UDR
UDR
$12.3B
| $59.3M | 0.12% |
1,288,061
+232,124
| +22% | +$11.7M |
|
171
Synchrony
SYF
$25.6B
| $58.8M | 0.12% |
2,129,146
+819,438
| +63% | +$28.4M |
|
172
Vistra
VST
$47.4B
| $58.6M | 0.12% |
2,564,840
+1,519,963
| +145% | +$37.6M |
|
173
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $57.8M | 0.12% |
995,600
+514,700
| +107% | +$32.1M |
|
174
SAP
SAP
$238B
| $57.6M | 0.12% |
634,504
+205,274
| +48% | +$20.5M |
|
175
RTX Corp
RTX
$301B
| $57.5M | 0.12% |
597,918
-59,082
| -9% | -$5.68M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.